Certain patients with advanced lung cancer may be saved by transplant

We also report on a troubling men's health trend, and on a discovery that could upend human biology assumptions based on ...
Medical Xpress

Molecular characterization of a rare type of lung cancer may point the way to a treatment target

Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature ...
STAT

Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says

Lung cancer patients hadn't been seen as candidates for organ transplant. Now a study finds patients did well.
Cure Today

Understanding Emerging Cell Therapy in Lung Cancer

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...
Medical Xpress

Large-scale gene analysis identifies new biomarkers and drug targets for lung adenocarcinoma

The researchers systematically studied genes and proteins across the whole genome and proteome in lung tumors and paired noncancerous lung tissues from more than 400 patients from North America, ...
WebMD

Six Factors That Affect How Your Lung Cancer Is Treated

Most lung cancers aren’t diagnosed until you’re older. In fact, on average, lung cancer shows up around the age of 70. The most common type is non-small-cell lung cancer (NSCLC), which grows from the ...

bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues

Affinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, ...